News
The partnership between Thomson X and Plano will seek to leverage on each other’s strengths to manage the rapidly increasing incidence of myopia.
The virtual care company disclosed all-time-high revenue and membership growth during 2020, yet offered 2021 projections below what investors anticipated.
Also: Medisafe lands $30 million in a round led by Sanofi and January AI rakes in $8.8 million for glycemic response tool.
Industry regulatory leaders outline the best approaches for digital health companies looking to make sense of FDA's long-in-the-tooth enforcement discretion guidelines.
Panelists from DTx West share how they successfully executed a digital therapeutic and payer relationship.
Respiray’s wearable device allegedly kills over 99% of viruses and bacteria with UV light and filter.
Panelists at this morning's DTx West discuss how governments worldwide are looking at digital therapeutics.
In a recent study funded and coauthored by the company, the EaseVRx program outperformed a non-interactive headset app across several self-reported pain and pain-interference measures.
Medication delivery is currently available in metro areas of New York City, Chicago, Minneapolis, Boston and Austin.
The process aims to ensure tools meet NHS standards.